Medicare Part D coverage · azilsartan medoxomil · RxCUI 1091654
azilsartan medoxomil 80 MG Oral Tablet [Edarbi]
Per the CMS 2026 Part D formulary file, azilsartan medoxomil 80 MG Oral Tablet [Edarbi] is covered by 2,608 Medicare Part D plans (51.6% of enrollable products), averaging Tier 3.3, with prior authorization required on 0% of covering formularies.
- 51.6%
- Plan coverage
- 2,608
- Plans covering
- T3.3
- Avg tier
- 0%
- Prior auth required
What the CMS Formulary Data Shows for azilsartan medoxomil 80 MG Oral Tablet [Edarbi]
Per the CMS 2026 Part D formulary file, azilsartan medoxomil 80 MG Oral Tablet [Edarbi] (RxNorm concept RXCUI 1091654, generic name azilsartan medoxomil) appears on 89 distinct formulary files spanning 2,608 Medicare Part D plan offerings - 51.6% of enrollable Part D products, mid-range placement; shopping across contracts changes access. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 3.3.
Real-world access to azilsartan medoxomil 80 MG Oral Tablet [Edarbi] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 19.1% require step therapy. 56.2% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 17,111 Part D beneficiaries filled azilsartan medoxomil 80 MG Oral Tablet [Edarbi] in 2023, with total plan-and-beneficiary spending of $36,819,212 and an average per-beneficiary annual cost of $2,151.79. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry azilsartan medoxomil 80 MG Oral Tablet [Edarbi] today.
Coverage Details
- Formularies covering
- 89
- Plans covering
- 2,608
- Coverage rate
- 51.6%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 19.1% of formularies
- Quantity limits
- 56.2% of formularies
2023 Medicare Spending
- Beneficiaries
- 17,111
- Total spending
- $36,819,212
- Avg per beneficiary
- $2,151.79
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering azilsartan medoxomil 80 MG Oral Tablet [Edarbi]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | No | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | No | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | No | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | No | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | No | $0 | MI |
| Gold Coast Health Plan Total Care Advantage (HMO D-SNP) | Ventura County Medi-Cal Managed Care Commission | T1 | No | $0 | CA |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) | Health Care Service Corporation | T1 | No | $0 | NM |
| SecureBlue (HMO D-SNP) | HMO Minnesota | T1 | No | $0 | MN |
| Hamaspik Medicare Choice (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $0 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Florida, Inc. | T1 | No | $4.80 | FL |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | Hcsc Insurance Services Company | T1 | No | $4.80 | TX |
| Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) | GHS Insurance Company | T1 | No | $5.00 | OK |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Michigan, Inc. | T1 | No | $8.80 | MI |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Illinois, Inc. | T1 | No | $15.20 | IL |
| WellSense Added Value (HMO) | Boston Medical Center Health Plan, Inc. | T1 | No | $21.70 | NH |
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Colorado, Inc. | T1 | No | $35.20 | CO |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF North Carolina, Inc. | T1 | No | $36.20 | NC |
Show the next 30 plans
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | No | $40.00 | NJ |
| ElderServe Star (HMO I-SNP) | Elderserve Health, Inc. | T1 | No | $58.80 | NY |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF NEW York, Inc. | T1 | No | $58.80 | NY |
| Leon MediExtra (HMO) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T2 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T2 | No | $0 | FL |
| Anthem I CareMore Medicare Advantage 2 (HMO-POS) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem I CareMore Chronic Care (HMO-POS C-SNP) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem I CareMore Home Care (HMO I-SNP) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem I CareMore Chronic Care (HMO-POS C-SNP) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem I CareMore Lung Care (HMO-POS C-SNP) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem I CareMore Kidney Care (HMO-POS C-SNP) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem I CareMore Lung Care (HMO-POS C-SNP) | Blue Cross OF California | T3 | No | $0 | CA |
| Anthem I CareMore Kidney Care (HMO-POS C-SNP) | Blue Cross OF California | T3 | No | $0 | CA |
| Wellpoint Lung Care (HMO-POS C-SNP) | Wellpoint Health Plans, Inc. | T3 | No | $0 | AZ |
| Wellpoint Chronic Care (HMO-POS C-SNP) | Wellpoint Health Plans, Inc. | T3 | No | $0 | AZ |
| Wellpoint Medicare Advantage 1 (HMO-POS) | Wellpoint Health Plans, Inc. | T3 | No | $0 | AZ |
| Wellpoint Premium Savings (HMO) | Wellpoint Health Plans, Inc. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Home Care (HMO I-SNP) | Wellpoint Health Plans, Inc. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Home Care (HMO I-SNP) | Wellpoint Health Plans, Inc. | T3 | No | $0 | AZ |
| Wellpoint Medicare Advantage 2 (HMO-POS) | Wellpoint Texas, Inc. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Home Care 2 (HMO I-SNP) | Wellpoint Texas, Inc. | T3 | No | $0 | AZ |
| Wellpoint Lung Care 2 (HMO-POS C-SNP) | Wellpoint Texas, Inc. | T3 | No | $0 | AZ |
| Wellpoint Chronic Care 2 (HMO-POS C-SNP) | Wellpoint Texas, Inc. | T3 | No | $0 | AZ |
| Wellpoint I CareMore Kidney Care (HMO-POS C-SNP) | Wellpoint Texas, Inc. | T3 | No | $0 | AZ |
| Anthem Chronic Care (HMO-POS C-SNP) | Healthkeepers, Inc. | T3 | No | $0 | VA |
| Anthem I CareMore Medicare Advantage (HMO-POS) | Blue Cross OF California Partnership Plan, Inc. | T3 | No | $0 | CA |
| Anthem I CareMore Premium Savings (HMO-POS) | Blue Cross OF California Partnership Plan, Inc. | T3 | No | $0 | CA |
| Anthem I CareMore Medicare Advantage (HMO-POS) | Blue Cross OF California Partnership Plan, Inc. | T3 | No | $0 | CA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is azilsartan medoxomil 80 MG Oral Tablet [Edarbi] covered by Medicare Part D?
Yes, azilsartan medoxomil 80 MG Oral Tablet [Edarbi] is covered by 2,608 Medicare Part D plans (51.6% of all Part D formularies).
What tier is azilsartan medoxomil 80 MG Oral Tablet [Edarbi] on Medicare Part D plans?
azilsartan medoxomil 80 MG Oral Tablet [Edarbi] averages Tier 3.3 across Part D plans, ranging from Tier 1 to Tier 6.
Does azilsartan medoxomil 80 MG Oral Tablet [Edarbi] require prior authorization?
0% of Part D formularies require prior authorization for azilsartan medoxomil 80 MG Oral Tablet [Edarbi]. Step therapy: 19.1%. Quantity limits: 56.2%.
How much does Medicare spend on azilsartan medoxomil 80 MG Oral Tablet [Edarbi]?
In 2023, total Medicare Part D spending on azilsartan medoxomil 80 MG Oral Tablet [Edarbi] was $36,819,212, covering 17,111 beneficiaries. The average spend per beneficiary was $2,151.79.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.